The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Research Report 2025

Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1991608

No of Pages : 89

Ask Your Query
Synopsis
The basic principle of chimeric antigen receptor T cell immunotherapy is to use the patient’s own immune cells to eliminate cancer cells. Among them, chimeric antigen receptor (CAR) is the core component of CAR-T, giving T cells HLA-independent recognition The ability of tumor antigens, which enables CAR-modified T cells to recognize a wider range of targets than the natural T cell surface receptor TCR. The basic design of CAR includes a tumor-associated antigen (TAA) binding region (usually derived from the scFV segment of the monoclonal antibody antigen binding region), an extracellular hinge region, a transmembrane region and an intracellular signal Area
The global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy include Pfizer, Novartis, Bristol Myers Squibb, Legend Biotech, Sorrento Therapeutics, CARSGEN Therapeutics，Ltd, Juno Therapeutics, Kite Pharma and Atara Biotherapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy.
Report Scope
The Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics，Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
Segment by Type
Allogeneic CAR T-Cells
Autologous CAR T-Cells
Segment by Application
Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Allogeneic CAR T-Cells
1.2.3 Autologous CAR T-Cells
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Perspective (2019-2030)
2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Growth Trends by Region
2.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Dynamics
2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Trends
2.3.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
2.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges
2.3.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue
3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2023
3.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030)
5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2019-2030)
6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024)
6.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2019-2030)
7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024)
7.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2019-2030)
9.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.1.4 Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.2.4 Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Detail
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.3.4 Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Legend Biotech
11.4.1 Legend Biotech Company Detail
11.4.2 Legend Biotech Business Overview
11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.4.4 Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.4.5 Legend Biotech Recent Development
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Detail
11.5.2 Sorrento Therapeutics Business Overview
11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.5.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.5.5 Sorrento Therapeutics Recent Development
11.6 CARSGEN Therapeutics，Ltd
11.6.1 CARSGEN Therapeutics，Ltd Company Detail
11.6.2 CARSGEN Therapeutics，Ltd Business Overview
11.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.6.4 CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.6.5 CARSGEN Therapeutics，Ltd Recent Development
11.7 Juno Therapeutics
11.7.1 Juno Therapeutics Company Detail
11.7.2 Juno Therapeutics Business Overview
11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.7.4 Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.7.5 Juno Therapeutics Recent Development
11.8 Kite Pharma
11.8.1 Kite Pharma Company Detail
11.8.2 Kite Pharma Business Overview
11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.8.4 Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.8.5 Kite Pharma Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Detail
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.9.4 Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Carina Biotech
11.10.1 Carina Biotech Company Detail
11.10.2 Carina Biotech Business Overview
11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.10.4 Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.10.5 Carina Biotech Recent Development
11.11 Guangzhou Xiangxue Pharmaceutical
11.11.1 Guangzhou Xiangxue Pharmaceutical Company Detail
11.11.2 Guangzhou Xiangxue Pharmaceutical Business Overview
11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
11.11.4 Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
11.11.5 Guangzhou Xiangxue Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Allogeneic CAR T-Cells
Table 3. Key Players of Autologous CAR T-Cells
Table 4. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region (2019-2024)
Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region (2025-2030)
Table 10. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends
Table 11. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
Table 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges
Table 13. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints
Table 14. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Players (2019-2024)
Table 16. Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy as of 2023)
Table 17. Ranking of Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Solution and Service
Table 21. Date of Enter into Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2019-2024)
Table 25. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2025-2030)
Table 27. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2019-2024)
Table 29. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2025-2030)
Table 31. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 49. Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 54. Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Bristol Myers Squibb Company Detail
Table 57. Bristol Myers Squibb Business Overview
Table 58. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 59. Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 60. Bristol Myers Squibb Recent Development
Table 61. Legend Biotech Company Detail
Table 62. Legend Biotech Business Overview
Table 63. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 64. Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 65. Legend Biotech Recent Development
Table 66. Sorrento Therapeutics Company Detail
Table 67. Sorrento Therapeutics Business Overview
Table 68. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 69. Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 70. Sorrento Therapeutics Recent Development
Table 71. CARSGEN Therapeutics，Ltd Company Detail
Table 72. CARSGEN Therapeutics，Ltd Business Overview
Table 73. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 74. CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 75. CARSGEN Therapeutics，Ltd Recent Development
Table 76. Juno Therapeutics Company Detail
Table 77. Juno Therapeutics Business Overview
Table 78. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 79. Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 80. Juno Therapeutics Recent Development
Table 81. Kite Pharma Company Detail
Table 82. Kite Pharma Business Overview
Table 83. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 84. Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 85. Kite Pharma Recent Development
Table 86. Atara Biotherapeutics Company Detail
Table 87. Atara Biotherapeutics Business Overview
Table 88. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 89. Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 90. Atara Biotherapeutics Recent Development
Table 91. Carina Biotech Company Detail
Table 92. Carina Biotech Business Overview
Table 93. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 94. Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 95. Carina Biotech Recent Development
Table 96. Guangzhou Xiangxue Pharmaceutical Company Detail
Table 97. Guangzhou Xiangxue Pharmaceutical Business Overview
Table 98. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
Table 99. Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 100. Guangzhou Xiangxue Pharmaceutical Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. Allogeneic CAR T-Cells Features
Figure 4. Autologous CAR T-Cells Features
Figure 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Diagnostic Center Case Studies
Figure 9. Others Case Studies
Figure 10. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Report Years Considered
Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region: 2023 VS 2030
Figure 14. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Players in 2023
Figure 15. Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2023
Figure 17. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 19. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 23. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region (2019-2030)
Figure 31. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 39. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2019-2030)
Figure 43. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 47. Bristol Myers Squibb Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 48. Legend Biotech Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 49. Sorrento Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 50. CARSGEN Therapeutics，Ltd Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 51. Juno Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 52. Kite Pharma Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 53. Atara Biotherapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 54. Carina Biotech Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 55. Guangzhou Xiangxue Pharmaceutical Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock